AU2002351798A1 - Methods and dosage forms for improving the bioavailability of therapeutic agents - Google Patents
Methods and dosage forms for improving the bioavailability of therapeutic agentsInfo
- Publication number
- AU2002351798A1 AU2002351798A1 AU2002351798A AU2002351798A AU2002351798A1 AU 2002351798 A1 AU2002351798 A1 AU 2002351798A1 AU 2002351798 A AU2002351798 A AU 2002351798A AU 2002351798 A AU2002351798 A AU 2002351798A AU 2002351798 A1 AU2002351798 A1 AU 2002351798A1
- Authority
- AU
- Australia
- Prior art keywords
- bioavailability
- improving
- methods
- dosage forms
- therapeutic agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Vascular Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01125761.5 | 2001-10-29 | ||
| EP01125761 | 2001-10-29 | ||
| PCT/EP2002/012062 WO2003037296A2 (fr) | 2001-10-29 | 2002-10-29 | Methodes et formes posologiques permettant d'ameliorer la biodisponibilite d'agents therapeutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002351798A1 true AU2002351798A1 (en) | 2003-05-12 |
Family
ID=8179102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002351798A Abandoned AU2002351798A1 (en) | 2001-10-29 | 2002-10-29 | Methods and dosage forms for improving the bioavailability of therapeutic agents |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1439820A2 (fr) |
| JP (1) | JP2005509643A (fr) |
| AU (1) | AU2002351798A1 (fr) |
| CA (1) | CA2466032A1 (fr) |
| MX (1) | MXPA04004035A (fr) |
| WO (1) | WO2003037296A2 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
| US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
| JP5269595B2 (ja) | 2005-09-09 | 2013-08-21 | アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー | １日１回投与用トラゾドン組成物 |
| US8795723B2 (en) * | 2005-09-09 | 2014-08-05 | Angelini Pharma Inc. | Sustained drug release compositions |
| JP5355002B2 (ja) | 2008-09-10 | 2013-11-27 | オリンパスメディカルシステムズ株式会社 | 浮き量合否判定システム、浮き量合否判定用表示システム、浮き量合否判定方法および浮き量合否判定用表示方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0998271B3 (fr) * | 1997-06-06 | 2014-10-29 | Depomed, Inc. | Formes de dosage de medicaments administres par voie orale a retention gastrique pour liberation lente de medicaments hautement solubles |
| DK1107741T3 (da) * | 1998-09-14 | 2003-11-17 | Ranbaxy Lab Ltd | Oralt administreret reguleret administrationssystem, der tilvejebringer tidsmæssig og rumlig regulering |
| AU5060499A (en) * | 1999-08-04 | 2001-03-05 | Ranbaxy Laboratories Limited | Hydrodynamically balanced oral drug delivery system |
| WO2001058424A1 (fr) * | 2000-02-09 | 2001-08-16 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Composition flottante de liberation de medicament |
-
2002
- 2002-10-29 WO PCT/EP2002/012062 patent/WO2003037296A2/fr not_active Ceased
- 2002-10-29 MX MXPA04004035A patent/MXPA04004035A/es unknown
- 2002-10-29 JP JP2003539640A patent/JP2005509643A/ja not_active Withdrawn
- 2002-10-29 EP EP02787522A patent/EP1439820A2/fr not_active Withdrawn
- 2002-10-29 CA CA002466032A patent/CA2466032A1/fr not_active Abandoned
- 2002-10-29 AU AU2002351798A patent/AU2002351798A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003037296A3 (fr) | 2003-12-24 |
| CA2466032A1 (fr) | 2003-05-08 |
| MXPA04004035A (es) | 2004-10-29 |
| EP1439820A2 (fr) | 2004-07-28 |
| JP2005509643A (ja) | 2005-04-14 |
| WO2003037296A2 (fr) | 2003-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002322719A1 (en) | Delivery of therapeutic capable agents | |
| AU2002310187A1 (en) | Inhibitors of protein kinase for the treatment of disease | |
| AU2002358270A1 (en) | Zero-order sustained released dosage forms and method of making the same | |
| AU2003261251A1 (en) | Methods of delivering therapeutic agents | |
| GB0111872D0 (en) | Therapeutic agents and methods | |
| AU2002332430A1 (en) | Methods of treating neuropilin-mediated diseases | |
| AU2002245629A1 (en) | Stabilized therapeutic and imaging agents | |
| EP1404343A4 (fr) | Combinaisons therapeutiques pour le traitement des carences hormonales | |
| AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
| HUP0400314A3 (en) | Pharmaceutical combinations for the treatment of cancer | |
| AU2002303502A1 (en) | Improved leads for the treatment of patients with chf | |
| AU2002334870B8 (en) | Combinations for the treatment of immunoinflammatory disorders | |
| EP1450803A4 (fr) | Nouvelles utilisations pour des agents therapeutiques antipaludiques | |
| AU2002240359A1 (en) | Pharmaceutical composition for the treatment of alopecia | |
| AU2002312897A1 (en) | Drugs for the treatment of the alzheimer disease | |
| GB0118383D0 (en) | Therapeutic methods | |
| AU2002359618A1 (en) | Medicinal compositions and therapeutic methods | |
| AU2002353739A1 (en) | Therapeutic compounds | |
| AU2002335667A1 (en) | Modified reoviral therapy | |
| AU2002351798A1 (en) | Methods and dosage forms for improving the bioavailability of therapeutic agents | |
| AU2002360696A1 (en) | Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis | |
| AU2002348105A1 (en) | Oral dosage forms for improving the bioavailability of therapeutic agents | |
| AU2002350344A1 (en) | Individualization of therapy with antihistamines | |
| HUP0402664A3 (en) | 2-indanylamino derivatives for the therapy of chronic pain | |
| AU6106801A (en) | Trans-clitoral administration of therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |